☆ 4.8 Review

Advances in Prostate-Specific Membrane Antigen (PSMA)-Targeted Phototheranostics of Prostate Cancer

SMALL STRUCTURES (2022)

Related references

Note: Only part of the references are listed.
Review Urology & Nephrology

An Updated Systematic Review on Focal Therapy in Localized Prostate Cancer: What Has Changed over the Past 5 Years?

Jana S. Hopstaken et al.

Summary: Focal therapy for prostate cancer has shown potential with less impact on continence and potency compared to radical treatment. High-intensity focused ultrasound and photodynamic therapy have shown promising results, but more high-quality evidence is needed for it to become standard treatment.

EUROPEAN UROLOGY (2022)

Add to Collection
Article Radiology, Nuclear Medicine & Medical Imaging

Utility of PET to Appropriately Select Patients for PSMA-Targeted Theranostics

Anna Eshghi et al.

Summary: PSMA is an attractive target for drug development in aggressive prostate cancers. Numerous PSMA-targeted radiopharmaceuticals have been developed for imaging and therapy. PSMA PET provides a method to better select patients for PSMA-targeted therapy, and ongoing clinical trials are studying PSMA-targeted therapeutic agents. PET parameters using PSMA and FDG PET/CT have been investigated as predictive and prognostic biomarkers. This article discusses the optimal use of PET for patient selection and provides an overview of choice of PET tracer, targeting molecule, therapeutic radioisotope, nonradioactive therapy, and cancer type.

CLINICAL NUCLEAR MEDICINE (2022)

Add to Collection
Article Radiology, Nuclear Medicine & Medical Imaging

A self-triggered radioligand therapy agent for fluorescence imaging of the treatment response in prostate cancer

Hongchuang Xu et al.

Summary: Radioligand therapy (RLT) targeting prostate-specific membrane antigen (PSMA) is a promising treatment option for mCRPC. A self-triggered probe 2 has been developed for fluorescence imaging of RLT-induced apoptosis by targeting the colocalization of PSMA and caspase-3.

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2022)

Add to Collection
Article Biochemistry & Molecular Biology

Imaging of prostate cancer: optimizing affinity to prostate specific membrane antigen by spacer modifications in a tumor spheroid model

Mena Asha Krishnan et al.

Summary: This study systematically investigates the impact of hydrophobic aromatic moieties in the peptide linker of an imaging probe on its affinity to PSMA protein and in vitro performance. The results suggest that aromatic groups in the spacer region can significantly affect deep tissue imaging of fluorescent bioconjugates, with bioconjugate 12 showing the highest affinity. Further conjugation to near-infrared agents could expand the applications of bioconjugate 12 in deep-tissue imaging and surgery.

JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS (2022)

Add to Collection
Editorial Material Radiology, Nuclear Medicine & Medical Imaging

18F-DCFPyL PET Acquisition, Interpretation, and Reporting: Suggestions After Food and Drug Administration Approval

Hong Song et al.

JOURNAL OF NUCLEAR MEDICINE (2022)

Add to Collection
Review Oncology

Advances in PSMA-targeted therapy for prostate cancer

Fujin Wang et al.

Summary: PSMA, a transmembrane glycoprotein highly expressed in prostate cancer, has been extensively studied as a molecular target for therapy. Various PSMA-targeted therapies, such as radioligand therapy, antibody-drug conjugates, and cellular immunotherapy, have shown significant progress in the treatment of PCa.

PROSTATE CANCER AND PROSTATIC DISEASES (2022)

Add to Collection
Review Oncology

Targeting PSMA Revolutionizes the Role of Nuclear Medicine in Diagnosis and Treatment of Prostate Cancer

Wietske I. Luining et al.

Summary: Imaging plays a crucial role in the accurate staging of prostate cancer, and targeting the prostate-specific membrane antigen (PSMA) protein has become of great clinical value. PSMA-based imaging techniques have shown superior detection rates compared to previous methods, and PSMA has also become a target for delivering radionuclide therapy. This review summarizes recent developments in nuclear medicine related to PSMA in prostate cancer diagnostics and targeted radionuclide therapy, highlighting the potential benefits of PSMA-positron emission tomography (PET) imaging and PSMA-based radioligand therapy in the treatment of metastatic castration-resistant prostate cancer (mCRPC).

CANCERS (2022)

Add to Collection
Article Urology & Nephrology

Activity and Adverse Events of Actinium-225-PSMA-617 in Advanced Metastatic Castration-resistant Prostate Cancer After Failure of Lutetium-177-PSMA

Benedikt Feuerecker et al.

Summary: Ac-225-PSMA-617 demonstrated measurable antitumor effect in late-stage mCRPC after Lu-177-PSMA failure. Grade 3/4 hematological side effects were observed in up to one-third of patients, and xerostomia led to treatment halt in a relevant number of patients.

EUROPEAN UROLOGY (2021)

Add to Collection
Review Chemistry, Physical

Surgical Navigation for Malignancies Guided by Near-Infrared-II Fluorescence Imaging

Rui-Qin Yang et al.

Summary: NIR-II fluorescence imaging has shown unique advantages in guiding tumor resection surgery, with improved penetration depths and signal-to-noise ratios. Its application in cancer surgery has demonstrated significant prospects for improving surgical outcomes.

SMALL METHODS (2021)

Add to Collection
Article Chemistry, Multidisciplinary

Magnetic Resonance Imaging of PSMA-Positive Prostate Cancer by a Targeted and Activatable Gd(III) MR Contrast Agent

Hao Li et al.

Summary: PSMA is a transmembrane protein highly expressed in aggressive prostate cancer, utilized in various imaging modalities as a biomarker. MR imaging provides detailed information but requires development of molecular contrast agents for improved sensitivity. In this study, targeted and activatable MR contrast agents were successfully used to differentiate between PSMA+ and PSMA- prostate cancer cells.

JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2021)

Add to Collection
Article Oncology

Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

Hyuna Sung et al.

Summary: The global cancer burden in 2020 saw an estimated 19.3 million new cancer cases and almost 10.0 million cancer deaths. Female breast cancer surpassed lung cancer as the most commonly diagnosed cancer, while lung cancer remained the leading cause of cancer death. These trends are expected to rise in 2040, with transitioning countries experiencing a larger increase compared to transitioned countries due to demographic changes and risk factors associated with globalization and a growing economy. Efforts to improve cancer prevention measures and provision of cancer care in transitioning countries will be crucial for global cancer control.

CA-A CANCER JOURNAL FOR CLINICIANS (2021)

Add to Collection
Article Oncology

The PSMA-targeting Half-life Extended BiTE Therapy AMG 160 has Potent Antitumor Activity in Preclinical Models of Metastatic Castration-resistant Prostate Cancer

Petra Deegen et al.

Summary: AMG 160, a bispecific T-cell engager immuno-oncology therapy targeting PSMA in mCRPC, demonstrates potent antitumor activity in vitro and in vivo. It shows enhanced cytotoxic activity when combined with diagnostic or therapeutic agents such as the PSMA-imaging agent, novel hormonal therapy, and immune checkpoint blockade. Preclinical data supports ongoing clinical evaluation in patients with mCRPC.

CLINICAL CANCER RESEARCH (2021)

Add to Collection
Review Urology & Nephrology

EAU-EANM-ESTRO-ESUR-SIOG Guidelines on Prostate Cancer-2020 Update. Part 1: Screening, Diagnosis, and Local Treatment with Curative Intent

Nicolas Mottet et al.

Summary: The 2020 EAU-EANM-ESTRO-ESUR-SIOG guidelines on screening, diagnosis, and treatment of localized prostate cancer summarize the most recent recommendations for clinical practice, including risk-adapted strategies, medical imaging utilization, biopsy techniques, patient classification, and treatment options. Recommendations include consideration of moderate hypofractionation for intermediate-risk patients and a combination of local treatment with long-term hormonal therapy for cN1 PCa patients.

EUROPEAN UROLOGY (2021)

Add to Collection
Article Chemistry, Multidisciplinary

Genetically-engineered anti-PSMA exosome mimetics targeting advanced prostate cancer in vitro and in vivo

Maja Severic et al.

Summary: The engineered anti-PSMA peptide-targeted EMs showed increased cellular internalization in PSMA positive PC cell lines and higher tumor targeting ability in vivo, indicating their potential as a promising drug delivery system for advanced prostate cancer.

JOURNAL OF CONTROLLED RELEASE (2021)

Add to Collection
Article Urology & Nephrology

A Phase 2/3 Prospective Multicenter Study of the Diagnostic Accuracy of Prostate Specific Membrane Antigen PET/CT with 18F-DCFPyL in Prostate Cancer Patients (OSPREY)

Kenneth J. Pienta et al.

Summary: The study aimed to evaluate the diagnostic performance of F-18-DCFPyL positron emission tomography/computerized tomography in detecting metastatic sites of prostate cancer. The results showed high specificity and positive predictive value, but moderate sensitivity.

JOURNAL OF UROLOGY (2021)

Add to Collection
Article Chemistry, Multidisciplinary

Large π-extended donor-acceptor polymers for highly efficient in vivo near-infrared photoacoustic imaging and photothermal tumor therapy

Jiangao Li et al.

Summary: A facile molecular design strategy based on large pi-extended donor-acceptor (L-pi-D-A) structure is reported for achieving semiconducting polymers (SPs) with highly efficient in vitro and in vivo photoacoustic imaging (PAI) and photothermal therapy (PTT) capabilities.

SCIENCE CHINA-CHEMISTRY (2021)

Add to Collection
Review Oncology

Preclinical and Clinical Status of PSMA-Targeted Alpha Therapy for Metastatic Castration-Resistant Prostate Cancer

Asta Juzeniene et al.

Summary: There is currently no cure for late stage metastatic prostate cancer, but targeted alpha therapy focusing on the overexpressed protein PSMA may offer a promising treatment option. This therapy utilizes radionuclides emitting alpha-particles to target PSMA, potentially providing a more effective and selective treatment option for patients.

CANCERS (2021)

Add to Collection
Article Oncology

Intra-Individual Comparison of 18F-PSMA-1007 and 18F-FDG PET/CT in the Evaluation of Patients With Prostate Cancer

Xing Zhou et al.

Summary: The study compared the application of 18F-FDG and 18F-PSMA-1007 in patients with prostate cancer and found that 18F-PSMA-1007 showed superiority in detection rate and tumor uptake. However, potential misdiagnosis issues exist, which require further vigilance and analysis to improve diagnostic accuracy.

FRONTIERS IN ONCOLOGY (2021)

Add to Collection
Article Andrology

Diagnostic accuracy of Raman spectroscopy for prostate cancer: a systematic review and meta-analysis

Jae Joon Park et al.

Summary: Raman spectroscopy shows high accuracy and potential for diagnosis and grading of prostate cancer, but further studies are needed to standardize and generalize its performance in clinical settings.

TRANSLATIONAL ANDROLOGY AND UROLOGY (2021)

Add to Collection
Editorial Material Oncology

FDA Approves Ga 68 PSMA-11 for Prostate Cancer Imaging

Shane C. Masters et al.

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2021)

Add to Collection
Review Oncology

Radiolabeled PSMA Inhibitors

Oliver C. Neels et al.

Summary: Prostate cancer remains a leading cause of cancer death in men, but recent developments in radiopharmaceuticals targeting PSMA show promise for diagnosis and therapy. Ongoing research is exploring new applications and improvements in patient care, with a focus on regulatory status and technical quality of PSMA-targeting radiopharmaceuticals. Emerging radiolabeling strategies and alternative therapies are also being investigated to further enhance patient treatment outcomes.

CANCERS (2021)

Add to Collection
Review Radiology, Nuclear Medicine & Medical Imaging

Prostate-specific Membrane Antigen PET in Prostate Cancer

Courtney Lawhn-Heath et al.

Summary: PSMA-targeted radiopharmaceuticals play a significant role in diagnosing and treating prostate cancer, with higher detection rates compared to conventional imaging and potential to change management plans, contributing positively to the advancement of prostate cancer imaging.

RADIOLOGY (2021)

Add to Collection
Article Chemistry, Multidisciplinary

A Highly Specific Multiple Enhancement Theranostic Nanoprobe for PET/MRI/PAI Image-Guided Radioisotope Combined Photothermal Therapy in Prostate Cancer

Lei Xia et al.

Summary: A novel biocompatible melanin nanoprobe coupled with a specific inhibitor is developed for targeted multimodal diagnosis and treatment of prostate cancer, demonstrating functionalities for photoacoustic imaging and photothermal therapy. The nanoparticles also have the capability for radioisotope therapy and photothermal therapy, showing a significant inhibitory effect on prostate cancer growth.

SMALL (2021)

Add to Collection
Article Chemistry, Physical

Supramolecular Tadalafil Nanovaccine for Cancer Immunotherapy by Alleviating Myeloid-Derived Suppressor Cells and Heightening Immunogenicity

Tian Zhang et al.

Summary: Utilizing FIT nanoparticles to co-deliver TAD and ICG effectively targets MDSCs and enhances tumor immunogenicity, promoting ICD induction and alleviation of MDSCs for enhancing photothermal immunotherapy. In vivo experiments demonstrate improved immune response and ICB efficacy.

SMALL METHODS (2021)

Add to Collection
Review Chemistry, Multidisciplinary

Recent advances in optical imaging of biomarkers in vivo

Xiangdan Meng et al.

Summary: The rapid development of nanotechnology and optical imaging techniques has led to the design and construction of various optical imaging strategies for sensitive and real-time imaging of cancer biomarkers or tumor tissue in vivo using intelligent nanoprobes. Special attention is focused on the progress of three optical modalities including fluorescence, photoacoustic imaging, and surface enhanced Raman scattering for biomarkers imaging in vivo, as well as the challenges and prospects of nanomaterial-based optical imaging in cancer diagnosis and personalized medicine.

NANO TODAY (2021)

Add to Collection
Article Multidisciplinary Sciences

A prostate-specific membrane antigen activated molecular rotor for real-time fluorescence imaging

Jingming Zhang et al.

Summary: The authors have developed a fluorescent molecular rotor probe targeting the prostate cancer marker PSMA, which can be used for real-time monitoring of endocytosis and tumor staging, and have demonstrated its suitability for in vivo imaging in a PCa xenograft model.

NATURE COMMUNICATIONS (2021)

Add to Collection
Review Nanoscience & Nanotechnology

Molecular imaging and disease theranostics with renal-clearable optical agents

Penghui Cheng et al.

Summary: Renal-clearable optical agents (RCOAs) are rapidly excreted from the body via the kidneys, making them suitable for targeted kidney imaging and early kidney injury detection, as well as deep tumor penetration and high-contrast tumor imaging.

NATURE REVIEWS MATERIALS (2021)

Add to Collection
Article Oncology

Diagnostic Accuracy of 68Ga-PSMA-11 PET for Pelvic Nodal Metastasis Detection Prior to Radical Prostatectomy and Pelvic Lymph Node Dissection A Multicenter Prospective Phase 3 Imaging Trial

Thomas A. Hope et al.

Summary: This study showed that in men with intermediate- to high-risk prostate cancer undergoing radical prostatectomy and lymph node dissection, the sensitivity and specificity of Ga-68-PSMA-11 PET were 0.40 and 0.95, respectively.

JAMA ONCOLOGY (2021)

Add to Collection
Review Chemistry, Multidisciplinary

Current trends and key considerations in the clinical translation of targeted fluorescent probes for intraoperative navigation

Renfa Liu et al.

Summary: The rapid development of fluorescence imaging for intraoperative navigation has led to further development of targeted fluorescent probes, with some already in clinical trials. NIR-II fluorescent probes demonstrate better performance in terms of penetration depths and signal-to-background ratios, but face challenges in transitioning from bench to bedside.

AGGREGATE (2021)

Add to Collection
Review Chemistry, Multidisciplinary

Most recent advances on enzyme-activatable optical probes for bioimaging

Ju Mei et al.

Summary: Enzymes are essential biological elements that play vital roles in cellular events and physiological processes. Optical imaging, with its high sensitivity and potential for enzyme-activatable probes, holds great promise for precise diagnosis and treatment of diseases.

AGGREGATE (2021)

Add to Collection
Review Chemistry, Multidisciplinary

Self-assembled magnetic nanomaterials: Versatile theranostics nanoplatforms for cancer

Shuren Wang et al.

Summary: Self-assembled magnetic nanomaterials are promising biomaterials with excellent physiochemical and biological characteristics, ideal for biomedical applications, especially in cancer treatment. They exhibit favorable nano-bio interfacial properties while maintaining their physical/chemical functionalities.

AGGREGATE (2021)

Add to Collection
Review Chemistry, Physical

Polymer-Based Therapeutic Nanoagents for Photothermal-Enhanced Combination Cancer Therapy

Nan Yang et al.

Summary: Scientists have made significant efforts in cancer control, with photothermal therapy (PTT) emerging as a promising treatment method. Polymer-based PTAs play a crucial role in cancer diagnosis and therapy, offering various advantages in terms of design, synthesis, biocompatibility, and therapeutic effects.

SMALL STRUCTURES (2021)

Add to Collection
Article Chemistry, Physical

Rational Design of Near-Infrared Aza-Platinum-Dipyrromethene-Based Nanophototherapy Agent with Multistage Enhancement for Synergistic Antitumor Therapeutics

Yunjian Xu et al.

Summary: In this study, a new NIR SPT agent APIDNs was designed and synthesized for synergistic PDT and PTT effects in inhibiting tumor cell growth in vivo, demonstrating superior therapy effects and negligible dark cytotoxicity. This novel strategy offers a new way to design new-generation NIR aza-metal-dipyrromethene-based dyes for developing superior SPT agents.

SMALL STRUCTURES (2021)

Add to Collection
Review Chemistry, Physical

Polymer-Based Therapeutic Nanoagents for Photothermal-Enhanced Combination Cancer Therapy

Nan Yang et al.

Summary: Photothermal therapy (PTT) has gained considerable attention in cancer treatment for its unique features, and polymer-based photothermal agents (PTAs) have been widely employed in cancer diagnosis and PTT due to their competitive advantages, including customizable designs, controllable synthesis, excellent biocompatibility, negligible cytotoxicity, satisfactory photostability, and desirable photothermal effects.

SMALL STRUCTURES (2021)

Add to Collection
Review Chemistry, Multidisciplinary

Gathering brings strength: How organic aggregates boost disease phototheranostics

Ji Qi et al.

Summary: Organic phototheranostic agents show great promise in disease theranostics, especially in modulating fluorescence emission, photoacoustic/photothermal production, and photodynamic processes using energy dissipation pathways of Jablonski diagram. They play a significant role in biomedical applications by achieving efficient treatment and inspiring new insights into the linkage between aggregate science and the biomedical field.

AGGREGATE (2021)

Add to Collection
Article Chemistry, Multidisciplinary

Dual contrast agents for fluorescence and photoacoustic imaging: evaluation in a murine model of prostate cancer

Wojciech G. Lesniak et al.

Summary: PSMA-targeted PAMAM dendrimers are promising for real-time detection of prostate cancer, with conjugate IV showing superior in vivo target specificity in male NOD-SCID mice and suitable physicochemical properties for FL and PA imaging.

NANOSCALE (2021)

Add to Collection
Article Materials Science, Biomaterials

A targeted near-infrared nanoprobe for deep-tissue penetration and imaging of prostate cancer

Mena Asha Krishnan et al.

Summary: This report presents the development of a novel near-infrared nanoprobe PSMA-QD655 for intraoperative navigation in prostate cancer surgery, showing high affinity and penetrative capacity in vitro 2D and 3D tissue models.

BIOMATERIALS SCIENCE (2021)

Add to Collection
Article Materials Science, Biomaterials

PSMA-targeted melanin-like nanoparticles as a multifunctional nanoplatform for prostate cancer theranostics

Liqun Dai et al.

Summary: PSMA-targeted multifunctional nanoplatform Ce6@PDA-DCL-PFP shows promising potential for precise diagnosis and treatment of prostate cancer. With enhanced ultrasound contrast signal and synergistic effect of PDT and PTT under dual-irradiation, this targeted probe exhibits superior therapeutic efficacy in vitro and in vivo, indicating a strong active targeting capacity for early theranostics of prostate cancer.

JOURNAL OF MATERIALS CHEMISTRY B (2021)

Add to Collection
Article Medicine, Research & Experimental

Photosensitizer-based multimodal PSMA-targeting ligands for intraoperative detection of prostate cancer

Yvonne H. W. Derks et al.

Summary: A novel PSMA-targeting ligand was developed and optimized for multimodal image-guided prostate cancer surgery combined with targeted photodynamic therapy, showing increased uptake in PSMA-expressing tumors and specificity in human samples.

THERANOSTICS (2021)

Add to Collection
Article Radiology, Nuclear Medicine & Medical Imaging

Hybrid Tracers Based on Cyanine Backbones Targeting Prostate-Specific Membrane Antigen: Tuning Pharmacokinetic Properties and Exploring Dye-Protein Interaction

Albertus W. Hensbergen et al.

JOURNAL OF NUCLEAR MEDICINE (2020)

Add to Collection
Article Oncology

Photodynamic Therapy Is an Effective Adjuvant Therapy for Image-Guided Surgery in Prostate Cancer

Xinning Wang et al.

CANCER RESEARCH (2020)

Add to Collection
Article Biochemistry & Molecular Biology

Long-Circulating Prostate-Specific Membrane Antigen-Targeted NIR Phototheranostic Agent

Marta Overchuk et al.

PHOTOCHEMISTRY AND PHOTOBIOLOGY (2020)

Add to Collection
Review Biochemical Research Methods

Image-Guided Surgery: Are We Getting the Most Out of Small Molecule Prostate-Specific-Membrane-Antigen-Targeted Tracers?

Albertus Wijnand Hensbergen et al.

BIOCONJUGATE CHEMISTRY (2020)

Add to Collection
Article Chemistry, Multidisciplinary

β-galactosidase responsive AIE fluorogene for identification and removal of senescent cancer cells

Zhengfeng Gao et al.

SCIENCE CHINA-CHEMISTRY (2020)

Add to Collection
Article Urology & Nephrology

Near-infrared fluorescence imaging for intraoperative margin assessment during robot-assisted partial nephrectomy

Katherine T. Sentell et al.

BJU INTERNATIONAL (2020)

Add to Collection
Article Chemistry, Medicinal

(S)-3-(Carboxyformamido)-2-(3-(carboxymethyl)ureido)propanoic Acid as a Novel PSMA Targeting Scaffold for Prostate Cancer Imaging

Xiaojiang Duan et al.

JOURNAL OF MEDICINAL CHEMISTRY (2020)

Add to Collection
Article Chemistry, Multidisciplinary

Functionalized NIR-II Semiconducting Polymer Nanoparticles for Single-cell to Whole-Organ Imaging of PSMA-Positive Prostate Cancer

Jiayingzi Wu et al.

SMALL (2020)

Add to Collection
Review Pharmacology & Pharmacy

Quicker, deeper and stronger imaging: A review of tumor-targeted, near-infrared fluorescent dyes for fluorescence guided surgery in the preclinical and clinical stages

Jianhua Jiao et al.

EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2020)

Add to Collection
Article Chemistry, Physical

Boosting O2•- Photogeneration via Promoting Intersystem-Crossing and Electron-Donating Efficiency of Aza-BODIPY-Based Nanoplatforms for Hypoxic-Tumor Photodynamic Therapy

Dapeng Chen et al.

SMALL METHODS (2020)

Add to Collection
Review Urology & Nephrology

Near-infrared Fluorescence Imaging with Indocyanine Green in Robot-assisted Partial Nephrectomy: Pooled Analysis of Comparative Studies

Alessandro Veccia et al.

EUROPEAN UROLOGY FOCUS (2020)

Add to Collection
Article Nanoscience & Nanotechnology

Cell Membrane-Inspired Polymeric Vesicles for Combined Photothermal and Photodynamic Prostate Cancer Therapy

Jiajia Hu et al.

ACS APPLIED MATERIALS & INTERFACES (2020)

Add to Collection
Article Chemistry, Multidisciplinary

Nanoparticles Yield Increased Drug Uptake and Therapeutic Efficacy upon Sequential Near-Infrared Irradiation

Dong Luo et al.

ACS NANO (2020)

Add to Collection
Article Biochemistry & Molecular Biology

Structural basis of prostate-specific membrane antigen recognition by the A9g RNA aptamer

Jakub Ptacek et al.

NUCLEIC ACIDS RESEARCH (2020)

Add to Collection
Article Chemistry, Multidisciplinary

Enabling AIEgens close assembly in tumor-overexpressed protein cluster for boosted image-guided cancer surgery

Junxiao Gao et al.

SCIENCE CHINA-CHEMISTRY (2020)

Add to Collection
Article Chemistry, Multidisciplinary

Endoplasmic reticulum targeted AIE bioprobe as a highly efficient inducer of immunogenic cell death

Jun Li et al.

SCIENCE CHINA-CHEMISTRY (2020)

Add to Collection
Review Chemistry, Physical

Construction of Smart Manganese Dioxide-Based All-in-One Nanoplatform for Cancer Diagnosis and Therapy

Xiangmei Liu et al.

SMALL METHODS (2020)

Add to Collection
Review Chemistry, Multidisciplinary

Emerging combination strategies with phototherapy in cancer nanomedicine

Zhongjian Xie et al.

CHEMICAL SOCIETY REVIEWS (2020)

Add to Collection
Review Chemistry, Physical

Recent Progress on Activatable Nanomedicines for Immunometabolic Combinational Cancer Therapy

Chi Zhang et al.

SMALL STRUCTURES (2020)

Add to Collection
Review Medicine, Research & Experimental

Mitochondria as a target in cancer treatment

Yu'e Liu et al.

MEDCOMM (2020)

Add to Collection
Review Chemistry, Physical

Recent Advances in Intraoperative Nerve Bioimaging: Fluorescence-Guided Surgery for Nerve Preservation

Ying Chen et al.

SMALL STRUCTURES (2020)

Add to Collection
Article Radiology, Nuclear Medicine & Medical Imaging

Synthesis and Preclinical Characterization of the PSMA-Targeted Hybrid Tracer PSMA-I&F for Nuclear and Fluorescence Imaging of Prostate Cancer

Margret Schottelius et al.

JOURNAL OF NUCLEAR MEDICINE (2019)

Add to Collection
Article Radiology, Nuclear Medicine & Medical Imaging

68Ga-PSMA PET/CT for monitoring response to 177Lu-PSMA-617 radioligand therapy in patients with metastatic castration-resistant prostate cancer

Alexander Heinzel et al.

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2019)

Add to Collection
Article Radiology, Nuclear Medicine & Medical Imaging

Detection Rate of 18F-Choline PET/CT and 68Ga-PSMA-HBED-CC PET/CT for Prostate Cancer Lymph Node Metastases with Direct Link from PET to Histopathology: Dependence on the Size of Tumor Deposits in Lymph Nodes

Cordula A. Jilg et al.

JOURNAL OF NUCLEAR MEDICINE (2019)

Add to Collection
Article Oncology

Assessment of 68Ga-PSMA-11 PET Accuracy in Localizing Recurrent Prostate Cancer: A Prospective Single-Arm Clinical Trial

Wolfgang P. Fendler et al.

JAMA ONCOLOGY (2019)

Add to Collection
Article Oncology

A Novel Fully Human Antibody targeting Extracellular Domain of PSMA Inhibits Tumor Growth in Prostate Cancer

Jieheng Wu et al.

MOLECULAR CANCER THERAPEUTICS (2019)

Add to Collection
Article Biochemistry & Molecular Biology

Tyrosine-based asymmetric urea ligand for prostate carcinoma: Tuning biological efficacy through in silico studies

Sagnik Sengupta et al.

BIOORGANIC CHEMISTRY (2019)

Add to Collection
Article Chemistry, Multidisciplinary

Fluorescence Detection of Prostate Cancer by an Activatable Fluorescence Probe for PSMA Carboxypeptidase Activity

Minoru Kawatani et al.

JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2019)

Add to Collection
Review Chemistry, Multidisciplinary

Advanced Nanotechnology Leading the Way to Multimodal Imaging-Guided Precision Surgical Therapy

Cong Wang et al.

ADVANCED MATERIALS (2019)

Add to Collection
Article Urology & Nephrology

Treatment Outcome, Toxicity, and Predictive Factors for Radioligand Therapy with 177Lu-PSMA-I&T in Metastatic Castration-resistant Prostate Cancer

Matthias M. Heck et al.

EUROPEAN UROLOGY (2019)

Add to Collection
Review Medicine, Research & Experimental

PSMA-targeting agents for radio- and fluorescence-guided prostate cancer surgery

Yvonne H. W. Derks et al.

THERANOSTICS (2019)

Add to Collection
Article Oncology

Evaluation of Novel Prostate-Specific Membrane Antigen-Targeted Near-Infrared Imaging Agent for Fluorescence-Guided Surgery of Prostate Cancer

Sumith A. Kularatne et al.

CLINICAL CANCER RESEARCH (2019)

Add to Collection
Article Immunology

Prostate-specific membrane antigen cleavage of vitamin B9 stimulates oncogenic signaling through metabotropic glutamate receptors

Charalambos Kaittanis et al.

JOURNAL OF EXPERIMENTAL MEDICINE (2018)

Add to Collection
Article Radiology, Nuclear Medicine & Medical Imaging

Comparison of 68Ga-PSMA-11 and 18F-Fluciclovine PET/CT in a Case Series of 10 Patients with Prostate Cancer Recurrence

Jeremie Calais et al.

JOURNAL OF NUCLEAR MEDICINE (2018)

Add to Collection
Article Radiology, Nuclear Medicine & Medical Imaging

PSMA-11-Derived Dual-Labeled PSMA Inhibitors for Preoperative PET Imaging and Precise Fluorescence-Guided Surgery of Prostate Cancer

Ann-Christin Baranski et al.

JOURNAL OF NUCLEAR MEDICINE (2018)

Add to Collection
Article Chemistry, Multidisciplinary

Prostate-Specific Membrane Antigen Targeted Gold Nanoparticles for Theranostics of Prostate Cancer

Joey Dacula Mangadlao et al.

ACS NANO (2018)

Add to Collection
Review Engineering, Biomedical

Optical molecular imaging for tumor detection and image-guided surgery

Chensu Wang et al.

BIOMATERIALS (2018)

Add to Collection
Article Biochemistry & Molecular Biology

Structure-activity relationships of succinimidyl-Cys-C(O)-Glu derivatives with different near-infrared fluorophores as optical imaging probes for prostate-specific membrane antigen

Daiko Matsuoka et al.

BIOORGANIC & MEDICINAL CHEMISTRY (2018)

Add to Collection
Review Urology & Nephrology

Survival and Complications Following Surgery and Radiation for Localized Prostate Cancer: An International Collaborative Review

Christopher J. D. Wallis et al.

EUROPEAN UROLOGY (2018)

Add to Collection
Article Biochemical Research Methods

Prostate-specific membrane antigen-targeted photoacoustic imaging of prostate cancer in vivo

Haichong K. Zhang et al.

JOURNAL OF BIOPHOTONICS (2018)

Add to Collection
Article Radiology, Nuclear Medicine & Medical Imaging

A Perspective on the Evolving Story of PSMA Biology, PSMA-Based Imaging, and Endoradiotherapeutic Strategies

Denise S. O'Keefe et al.

JOURNAL OF NUCLEAR MEDICINE (2018)

Add to Collection
Review Urology & Nephrology

Imaging the High-risk Prostate Cancer Patient: Current and Future Approaches to Staging

Marc A. Bjurlin et al.

UROLOGY (2018)

Add to Collection
Article Medicine, Research & Experimental

Image-guided surgery in cancer: A strategy to reduce incidence of positive surgical margins

Kathryn R. Tringale et al.

WILEY INTERDISCIPLINARY REVIEWS-SYSTEMS BIOLOGY AND MEDICINE (2018)

Add to Collection
Article Biochemical Research Methods

Tuning Pharmacokinetics to Improve Tumor Accumulation of a Prostate-Specific Membrane Antigen-Targeted Phototheranostic Agent

Kara M. Harmatys et al.

BIOCONJUGATE CHEMISTRY (2018)

Add to Collection
Review Medicine, General & Internal

Review of Gallium-68 PSMA PET/CT Imaging in the Management of Prostate Cancer

Nat P. Lenzo et al.

DIAGNOSTICS (2018)

Add to Collection
Review Medicine, General & Internal

The Diagnosis and Treatment of Prostate Cancer A Review

Mark S. Litwin et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2017)

Add to Collection
Article Radiology, Nuclear Medicine & Medical Imaging

Glu-Ureido-Based Inhibitors of Prostate-Specific Membrane Antigen: Lessons Learned During the Development of a Novel Class of Low-Molecular-Weight Theranostic Radiotracers

Klaus Kopka et al.

JOURNAL OF NUCLEAR MEDICINE (2017)

Add to Collection
Article Radiology, Nuclear Medicine & Medical Imaging

Clinical PET Imaging in Prostate Cancer

Kathryn L. Wallitt et al.

RADIOGRAPHICS (2017)

Add to Collection
Article Biochemistry & Molecular Biology

PSMA redirects cell survival signaling from the MAPK to the PI3K-AKT pathways to promote the progression of prostate cancer

Leslie Ann Caromile et al.

SCIENCE SIGNALING (2017)

Add to Collection
Article Biochemistry & Molecular Biology

PSMA redirects cell survival signaling from the MAPK to the PI3K-AKT pathways to promote the progression of prostate cancer

Leslie Ann Caromile et al.

SCIENCE SIGNALING (2017)

Add to Collection
Article Chemistry, Medicinal

Synthesis and evaluation of a novel near-infrared fluorescent probe based on succinimidyl-Cys-C(O)-Glu that targets prostate-specific membrane antigen for optical imaging

Daiko Matsuoka et al.

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2017)

Add to Collection
Article Chemistry, Multidisciplinary

PSMA-targeted contrast agents for intraoperative imaging of prostate cancer

Kai Bao et al.

CHEMICAL COMMUNICATIONS (2017)

Add to Collection
Article Chemistry, Medicinal

[18F]Fluorobenzoyllysinepentanedioic Acid Carbamates: New Scaffolds for Positron Emission Tomography (PET) Imaging of Prostate-Specific Membrane Antigen (PSMA)

Xing Yang et al.

JOURNAL OF MEDICINAL CHEMISTRY (2016)

Add to Collection
Article Oncology

New Strategies in Prostate Cancer: Prostate-Specific Membrane Antigen (PSMA) Ligands for Diagnosis and Therapy

Uwe Haberkorn et al.

CLINICAL CANCER RESEARCH (2016)

Add to Collection
Article Biochemical Research Methods

Photoacoustic imaging with an acoustic lens detects prostate cancer cells labeled with PSMA-targeting near-infrared dye-conjugates

Vikram Dogra et al.

JOURNAL OF BIOMEDICAL OPTICS (2016)

Add to Collection
Article Urology & Nephrology

Diagnostic Efficacy of 68Gallium-PSMA Positron Emission Tomography Compared to Conventional Imaging for Lymph Node Staging of 130 Consecutive Patients with Intermediate to High Risk Prostate Cancer

Tobias Maurer et al.

JOURNAL OF UROLOGY (2016)

Add to Collection
Article Oncology

Development and Application of a Novel Model System to Study Active and Passive Tumor Targeting

Amarnath Mukherjee et al.

MOLECULAR CANCER THERAPEUTICS (2016)

Add to Collection
Article Radiology, Nuclear Medicine & Medical Imaging

Radiolabeled enzyme inhibitors and binding agents targeting PSMA: Effective theranostic tools for imaging and therapy of prostate cancer

Maroor Raghavan Ambikalmajan Pillai et al.

NUCLEAR MEDICINE AND BIOLOGY (2016)

Add to Collection
Review Radiology, Nuclear Medicine & Medical Imaging

Current Status of Prostate-Specific Membrane Antigen Targeting in Nuclear Medicine: Clinical Translation of Chelator Containing Prostate-Specific Membrane Antigen Ligands Into Diagnostics and Therapy for Prostate Cancer

Clemens Kratochwil et al.

SEMINARS IN NUCLEAR MEDICINE (2016)

Add to Collection
Article Oncology

A novel anti-PSMA human scFv has the potential to be used as a diagnostic tool in prostate cancer

Donghui Han et al.

ONCOTARGET (2016)

Add to Collection
Article Multidisciplinary Sciences

In vivo imaging of prostate cancer using an anti-PSMA scFv fragment as a probe

Claire Mazzocco et al.

SCIENTIFIC REPORTS (2016)

Add to Collection
Article Oncology

Real-time, Near-Infrared Fluorescence Imaging with an Optimized Dye/Light Source/Camera Combination for Surgical Guidance of Prostate Cancer

Brian P. Neuman et al.

CLINICAL CANCER RESEARCH (2015)

Add to Collection
Review Nanoscience & Nanotechnology

Near-infrared fluorescent probes in cancer imaging and therapy: an emerging field

Xiaomin Yi et al.

INTERNATIONAL JOURNAL OF NANOMEDICINE (2014)

Add to Collection
Article Oncology

Development of Targeted Near-Infrared Imaging Agents for Prostate Cancer

Xinning Wang et al.

MOLECULAR CANCER THERAPEUTICS (2014)

Add to Collection
Article Medicine, Research & Experimental

Enhancing Targeted Tumor Treatment by Near IR Light-Activatable Photodynamic-Photothermal Synergistic Therapy

Zhen Fan et al.

MOLECULAR PHARMACEUTICS (2014)

Add to Collection
Article Endocrinology & Metabolism

Comparative analysis of monoclonal antibodies against prostate-specific membrane antigen (PSMA)

J. Tykvart et al.

PROSTATE (2014)

Add to Collection
Article Chemistry, Medicinal

Minibody-Indocyanine Green Based Activatable Optical Imaging Probes: The Role of Short Polyethylene Glycol Linkers

Rira Watanabe et al.

ACS MEDICINAL CHEMISTRY LETTERS (2014)

Add to Collection
Article Biochemical Research Methods

Development of Tumor-Targeted Near Infrared Probes for Fluorescence Guided Surgery

Lindsay E. Kelderhouse et al.

BIOCONJUGATE CHEMISTRY (2013)

Add to Collection
Article Biochemical Research Methods

Synthesis and Biological Evaluation of Low Molecular Weight Fluorescent Imaging Agents for the Prostate-Specific Membrane Antigen

Ying Chen et al.

BIOCONJUGATE CHEMISTRY (2012)

Add to Collection
Article Urology & Nephrology

Robot-Assisted and Laparoscopic Partial Nephrectomy with Near Infrared Fluorescence Imaging

Scott Tobis et al.

JOURNAL OF ENDOUROLOGY (2012)

Add to Collection
Article Chemistry, Multidisciplinary

Sequential SPECT and Optical Imaging of Experimental Models of Prostate Cancer with a Dual Modality Inhibitor of the Prostate-Specific Membrane Antigen

Sangeeta Ray Banerjee et al.

ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2011)

Add to Collection
Article Biochemical Research Methods

Targeted, Activatable, In Vivo Fluorescence Imaging of Prostate-Specific Membrane Antigen (PSMA) Positive Tumors Using the Quenched Humanized J591 Antibody-Indocyanine Green (ICG) Conjugate

Takahito Nakajima et al.

BIOCONJUGATE CHEMISTRY (2011)

Add to Collection
Article Oncology

Prostate-specific membrane antigen-targeted photodynamic therapy induces rapid cytoskeletal disruption

Tiancheng Liu et al.

CANCER LETTERS (2010)

Add to Collection
Article Oncology

Effects of potential calcium sensing receptor inducers on promoting chemosensitivity of human colon carcinoma cells

Xize Wang et al.

INTERNATIONAL JOURNAL OF ONCOLOGY (2010)

Add to Collection
Article Radiology, Nuclear Medicine & Medical Imaging

Single-Dose Intravenous Toxicity Study of IRDye 800CW in Sprague-Dawley Rats

Milton V. Marshall et al.

MOLECULAR IMAGING AND BIOLOGY (2010)

Add to Collection
Article Dermatology

Silicon Phthalocyanine (Pc 4) Photodynamic Therapy Is a Safe Modality for Cutaneous Neoplasms: Results of a Phase 1 Clinical Trial

Elma D. Baron et al.

LASERS IN SURGERY AND MEDICINE (2010)

Add to Collection
Article Biochemistry & Molecular Biology

A low molecular weight PSMA-based fluorescent imaging agent for cancer

Ying Chen et al.

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2009)

Add to Collection
Article Endocrinology & Metabolism

In Vitro Targeted Photodynamic Therapy With a Pyropheophorbide-a Conjugated Inhibitor of Prostate-Specific Membrane Antigen

Tiancheng Liu et al.

PROSTATE (2009)

Add to Collection
Article Urology & Nephrology

Visualizing Human Prostate Cancer Cells in Mouse Skeleton Using Bioconjugated Near-infrared Fluorescent Quantum Dots

Chunmeng Shi et al.

UROLOGY (2009)

Add to Collection
Article Oncology

Phase I trial of 177lutetium-labeled J591, a monoclonal antibody to prostate-specific membrane antigen, in patients with androgen-independent prostate cancer

NH Bander et al.

JOURNAL OF CLINICAL ONCOLOGY (2005)

Add to Collection
Article Biotechnology & Applied Microbiology

In vivo cancer targeting and imaging with semiconductor quantum dots

XH Gao et al.

NATURE BIOTECHNOLOGY (2004)

Add to Collection
Article Urology & Nephrology

Targeting metastatic prostate cancer with radiolabeled monoclonal antibody J591 to the extracellular domain of prostate specific membrane antigen

NH Bander et al.

JOURNAL OF UROLOGY (2003)

Add to Collection
Review Pharmacology & Pharmacy

PSMA specific antibodies and their diagnostic and therapeutic use

EH Holmes

EXPERT OPINION ON INVESTIGATIONAL DRUGS (2001)

Add to Collection
Article Chemistry, Medicinal

Design of remarkably simple, yet potent urea-based inhibitors of glutamate carboxypeptidase II (NAALADase)

AP Kozikowski et al.

JOURNAL OF MEDICINAL CHEMISTRY (2001)

Add to Collection
Webinars Posters Questions Hubs Funding Journals Papers Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.